Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:42 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | ARMISTICE CAPITAL LLC | 1,500,063 0.830% | 1,500,063 (New Position) | View |
| 2024-11-14 4:40 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Alyeska Investment Group L.P. | 0 0.000% | -5,855,597 (Position Closed) | View |
| 2024-10-16 09:01 am Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Empery Asset Management LP | 1,739,864 1.340% | 1,739,864 (New Position) | View |
| 2024-06-20 4:01 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | L1 Capital Global Opportunities Master Fund Ltd. | 432,187 9.990% | 432,187 (New Position) | View |
| 2024-02-14 4:00 pm Unchanged | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | TANG CAPITAL PARTNERS LP | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-14 3:56 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | ARMISTICE CAPITAL LLC | 3,770,000 6.710% | 3,770,000 (New Position) | View |
| 2024-02-14 1:55 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Alyeska Investment Group L.P. | 5,855,597 9.990% | 5,855,597 (New Position) | View |
| 2024-01-11 4:53 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Empery Asset Management LP | 55,675,674 9.990% | 55,675,674 (New Position) | View |
| 2024-01-03 4:23 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | SABBY MANAGEMENT LLC | 5,205,348 11.000% | 5,205,348 (New Position) | View |
| 2023-02-14 4:00 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | TANG CAPITAL PARTNERS LP | 4,500,419 7.400% | 219,503 (+5.13%) | View |
| 2022-12-27 5:05 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | TANG CAPITAL PARTNERS LP | 4,280,916 7.400% | 4,280,916 (New Position) | View |
| 2022-07-08 4:52 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | BlackRock Inc. BLK | 341,736 1.100% | 341,736 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | BlackRock Inc. BLK | 30,631,558 6.200% | 30,631,558 (New Position) | View |
| 2021-02-16 5:09 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | ARMISTICE CAPITAL LLC | 0 0.000% | -598,399 (Position Closed) | View |
| 2021-02-16 10:09 am Sale | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | CVI Investments Inc. | 111,250 0.100% | -1,131,265 (-91.05%) | View |
| 2021-02-11 5:15 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Altium Capital Management LP | 0 0.000% | -1,546,082 (Position Closed) | View |
| 2021-02-10 8:20 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | RENAISSANCE TECHNOLOGIES LLC | 271,164 0.140% | -49,061 (-15.32%) | View |
| 2021-01-04 6:42 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | SABBY MANAGEMENT LLC | 100,000 11.000% | -1,135,771 (-91.91%) | View |
| 2020-02-14 3:39 pm Unchanged | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Altium Capital Management LP | 1,546,082 9.900% | 0 (Unchanged) | View |
| 2020-02-14 3:09 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | ARMISTICE CAPITAL LLC | 598,399 9.990% | 598,399 (New Position) | View |